The combination of ERC and exercise maintenance yielded a synergistic effect, maximizing the reduction in MACE and all-cause death risks, highlighting integrated management in AF.
Abstract
Background
The benefit of combining early rhythm control (ERC) and exercise habit change in atrial fibrillation (AF) is unknown.
Objective
To evaluate the primary outcomes - major adverse cardiovascular event (MACE) and all-cause death - according to the combination of ERC status and exercise habit change.
Method
From the National Health Information Database, we included 161,379 patients diagnosed with AF. Rhythm control initiated within two-year from AF diagnosis was defined as ERC. Based on the status of regular exercise at serial health examinations before and after AF diagnosis, exercise habit change was categorized into persistent non-exercisers, exercise dropouts, new exercisers, and exercise maintainers.
RESULT
During a mean follow-up of 4.6 years, ERC was associated with a lower risk of MACE and all-cause death; adjusted hazard ratio (aHR) and 95% confidence interval (CI) was 0.832 (0.797-0.868) for MACE and 0.953 (0.915-0.992) for all-cause death (both p<0.001). Exercise maintenance was also associated with a lower risk of MACE and all-cause death: adjusted HR (95% CI)=0.822 (0.763-0.886) for MACE and 0.708 (0.658-0.762) for all-cause death (both p<0.001). There was a progressive decrease in the risk of MACE and all-cause death as AF patient engaged in ERC or regular exercise; the combination of ERC and exercise maintenance provided the greatest benefit, associated with the lowest risk of MACE [aHR (95% CI)=0.641 (0.576-0.713)] and all-cause death [aHR (95%CI)=0.564 (0.499-0.636)], both p<0.001.
Conclusion
The combination of ERC and exercise maintenance yielded a synergistic effect, maximizing the reduction in MACE and all-cause death risks, highlighting integrated management in AF.
BACKGROUND AND AIMS
Early rhythm-control improves cardiovascular outcomes in patients with atrial fibrillation (AF). Its effectiveness in patients with cancer is unclear. This study evaluated the effects of cancer history on early rhythm-control in the EAST-AFNET 4 trial.
METHODS
This secondary analysis of EAST-AFNET...
D. Ismaili, A. Suling, K. Borof et al.· Europace· 0 citations
Background: Atrial fibrillation is the most common cardiac arrhythmia and increases the risk of stroke, heart failure, and mortality. NVAF accounts for most AF cases, with treatment focused on anticoagulation and rate or rhythm control. DOAC use has increased globally, but evidence from Bangladesh remains limited. This...
M. Sufian, A. N. M. Monowarul Kadir, Maryam Zahid et al.· Scholars Journal of Applied...· 0 citations
In this large cohort with AS, AF was independently associated with an increased risk of both all-cause and cardiovascular mortality, regardless of treatment strategy or AS flow-gradient pattern.
Thomas Reed-Métayer, Pier-Anthony Bouchard, Sébastien Hecht et al.· Journal of the American Hear...· 0 citations
Prediabetes was associated with a modestly increased risk of new-onset AF, particularly persistent AF, and was associated with HF development among individuals without established arrhythmia.
K. Ukita, Lotta Nowak, F. Schmelter et al.· Clinical Research in Cardiol...· 0 citations
Less than half of AF patients had AF-symptom scores or arrhythmia burdens reflecting patient-defined treatment success, and factors associated with reaching patient reported outcome goals were distinct from those associated with arrhythmia burden goals.
Alexander E. Kolomaya, Brian Zenger, Michael Torre et al.· Critical Pathways in Cardiol...· 1 citation
BACKGROUND
Oral anticoagulation (OAC) remains underused in patients with atrial fibrillation or flutter at high risk of ischemic stroke. We aimed to characterize documented OAC prescribing at diagnosis and during 1-year follow-up and identify factors associated with baseline OAC prescribing.
METHODS
Using electronic...
P. Gouda, Josephine Harrington, Kelly Arps et al.· Circulation. Population heal...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.